Furthermore, a crucial role of the TRAF2-NFκB axis as an adaptive survival mechanism in response to EGFR oncogene inhibition has been reported for lung cancer and there is also evidence that TRAF2 expression confers resistance against irradiation [52,249]. This evidence concerns the gene TRAF2 and lung carcinoma.